Laser versus shockwaves for myofascial pain · Randomized trial · 2024
Does shockwave or laser ease neck and upper-back muscle pain more?
In this trial, three shockwave sessions plus home exercises lowered neck and upper-back pain from about 7 to about 4 out of 10 a month after treatment. People who had laser with the same exercises improved by a similar amount.
Both helped- people with long-lasting neck or upper-back muscle pain
- 46
- shockwave sessions, 5–8 days apart
- 3
- month of follow-up after treatment
- 1
Good to know: Everyone did the same home exercises.
Özyiğit E, Erdal A Archives of Basic and Clinical Research, 2024 · Read the paper ↗
What happened
Neck and upper-back pain
0–10 pain scale · start, end of treatment and one month later
Shockwave + exercisesLaser + exercises
Show the numbers
| Group | Start | End of treatment | 1 month later |
|---|---|---|---|
| Shockwave + exercises | 7.1 | 5.2 | 3.9 |
| Laser + exercises | 6.8 | 4.3 | 3.1 |
The treatment
Shockwave + exercises
Shockwave, 3 sessions
- Sessions
- 3
- Pulses
- 2,000 per session · aimed at the two most tender points
- Strength
- 2.0bar (10–15 pulses per second)
- Numbing
- Not mentioned
- Device
- BTL-5000 SWT compressor POWER
- Everyone also got
- Home posture, range-of-motion and stretching exercises, 3 sets of 10 daily for 2 months
Compared with: Laser (15 sessions over three weeks) with the same home exercises
Settings are what each study used, not a prescription.
Who took part
46 people with neck or upper-back muscle pain for at least three months and trigger points in the trapezius or back muscles; average age 35. People with fibromyalgia were excluded.
Side effects
The study does not report side effects.
All the numbers and the full appraisal
The results, in numbers.
Patients with at least three months of neck/dorsal myofascial symptoms, diagnosed by Travell and Simons criteria, with trapezius or paraspinal trigger points; 20 analyzed per treatment. Mean age was 35.3 years. Fibromyalgia and severe cervical disc disease were excluded.
46 randomized overall; six excluded for missing assessment, arm-specific allocation and attrition not reported; 20 analyzed per arm.
46 randomized overall; six excluded for missing assessment, arm-specific allocation and attrition not reported; 20 analyzed per arm.
Visual Analogue Scale4 reported outcomes
Pain intensity
Visual Analogue Scale Points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Laser plus exercise | 20 | 6.8 (SD 1.3) | 4.3 (SD 1.5) |
| ESWT plus exercise | 20 | 7.1 (SD 1.9) | 5.2 (SD 1.9) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT change
Mann–Whitney U test of changes
No statistically significant difference in change between treatments.
Analysis details and source
Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.
Pain intensity
Visual Analogue Scale Points
| Group | n | Baseline | Reported change |
|---|---|---|---|
| Laser plus exercise | 20 | — | 2.4 (SD 1.7) |
| ESWT plus exercise | 20 | — | 1.9 (SD 1.4) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT
Mann–Whitney U
Source-reported improvement magnitude; no superior treatment identified.
Analysis details and source
Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.
Pain intensity
Visual Analogue Scale Points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Laser plus exercise | 20 | 6.8 (SD 1.3) | 3.1 (SD 2) |
| ESWT plus exercise | 20 | 7.1 (SD 1.9) | 3.9 (SD 2.6) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT change
Mann–Whitney U test of changes
No statistically significant difference in change between treatments.
Analysis details and source
Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.
Pain intensity
Visual Analogue Scale Points
| Group | n | Baseline | Reported change |
|---|---|---|---|
| Laser plus exercise | 20 | — | 3.7 (SD 2.2) |
| ESWT plus exercise | 20 | — | 3.2 (SD 1.9) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT
Mann–Whitney U
Source-reported improvement magnitude; no superior treatment identified.
Analysis details and source
Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.
Algometer4 reported outcomes
Pressure pain threshold
Algometer kg
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Laser plus exercise | 20 | 2.5 (SD 1) | 3 (SD 1.2) |
| ESWT plus exercise | 20 | 2.1 (SD 0.9) | 3 (SD 1.2) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT change
Mann–Whitney U test of changes
No statistically significant difference in change between treatments.
Analysis details and source
Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.
Pressure pain threshold
Algometer kg
| Group | n | Baseline | Reported change |
|---|---|---|---|
| Laser plus exercise | 20 | — | 0.4 (SD 0.8) |
| ESWT plus exercise | 20 | — | 0.8 (SD 0.9) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT
Mann–Whitney U
Source-reported improvement magnitude; no superior treatment identified.
Analysis details and source
Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.
Pressure pain threshold
Algometer kg
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Laser plus exercise | 20 | 2.5 (SD 1) | 3.7 (SD 1.1) |
| ESWT plus exercise | 20 | 2.1 (SD 0.9) | 3.5 (SD 1.3) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT change
Mann–Whitney U test of changes
No statistically significant difference in change between treatments.
Analysis details and source
Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.
Pressure pain threshold
Algometer kg
| Group | n | Baseline | Reported change |
|---|---|---|---|
| Laser plus exercise | 20 | — | 1.1 (SD 1.2) |
| ESWT plus exercise | 20 | — | 1.4 (SD 1) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT
Mann–Whitney U
Source-reported improvement magnitude; no superior treatment identified.
Analysis details and source
Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.
Beck Depression Inventory4 reported outcomes
Depressive symptoms
Beck Depression Inventory Points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Laser plus exercise | 20 | 18.4 (SD 10.8) | 16.3 (SD 8.9) |
| ESWT plus exercise | 20 | 13.6 (SD 7.7) | 11.3 |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT change
Mann–Whitney U test of changes
No statistically significant difference in change between treatments.
Analysis details and source
Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.
Depressive symptoms
Beck Depression Inventory Points
| Group | n | Baseline | Reported change |
|---|---|---|---|
| Laser plus exercise | 20 | — | 2.1 (SD 3.5) |
| ESWT plus exercise | 20 | — | 2.3 (SD 3.2) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT
Mann–Whitney U
Source-reported improvement magnitude; no superior treatment identified.
Analysis details and source
Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.
Depressive symptoms
Beck Depression Inventory Points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Laser plus exercise | 20 | 18.4 (SD 10.8) | 15.5 (SD 8.3) |
| ESWT plus exercise | 20 | 13.6 (SD 7.7) | 11.6 (SD 7.4) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT change
Mann–Whitney U test of changes
No statistically significant difference in change between treatments.
Analysis details and source
Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.
Depressive symptoms
Beck Depression Inventory Points
| Group | n | Baseline | Reported change |
|---|---|---|---|
| Laser plus exercise | 20 | — | 3 (SD 4.8) |
| ESWT plus exercise | 20 | — | 2 (SD 3) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT
Mann–Whitney U
Source-reported improvement magnitude; no superior treatment identified.
Analysis details and source
Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.
SF-36 physical component4 reported outcomes
Physical health
SF-36 physical component Points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Laser plus exercise | 20 | 38.2 (SD 7.9) | 40.7 (SD 8.7) |
| ESWT plus exercise | 20 | 36.7 (SD 5.8) | 41.2 (SD 6.7) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT change
Mann–Whitney U test of changes
No statistically significant difference in change between treatments.
Analysis details and source
Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.
Physical health
SF-36 physical component Points
| Group | n | Baseline | Reported change |
|---|---|---|---|
| Laser plus exercise | 20 | — | 2.5 (SD 4.3) |
| ESWT plus exercise | 20 | — | 4.5 (SD 4.9) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT
Mann–Whitney U
Source-reported improvement magnitude; no superior treatment identified.
Analysis details and source
Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.
Physical health
SF-36 physical component Points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Laser plus exercise | 20 | 38.2 (SD 7.9) | 42.3 (SD 8) |
| ESWT plus exercise | 20 | 36.7 (SD 5.8) | 43.6 (SD 6) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT change
Mann–Whitney U test of changes
No statistically significant difference in change between treatments.
Analysis details and source
Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.
Physical health
SF-36 physical component Points
| Group | n | Baseline | Reported change |
|---|---|---|---|
| Laser plus exercise | 20 | — | 4.2 (SD 4.6) |
| ESWT plus exercise | 20 | — | 6.9 (SD 7.2) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT
Mann–Whitney U
Source-reported improvement magnitude; no superior treatment identified.
Analysis details and source
Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.
SF-36 mental component4 reported outcomes
Mental health
SF-36 mental component Points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Laser plus exercise | 20 | 38.7 (SD 9.1) | 41.9 (SD 7.7) |
| ESWT plus exercise | 20 | 43.5 (SD 12.4) | 46.7 (SD 9.5) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT change
Mann–Whitney U test of changes
No statistically significant difference in change between treatments.
Analysis details and source
Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.
Mental health
SF-36 mental component Points
| Group | n | Baseline | Reported change |
|---|---|---|---|
| Laser plus exercise | 20 | — | 3.2 (SD 5.5) |
| ESWT plus exercise | 20 | — | 3.1 (SD 6.7) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT
Mann–Whitney U
Source-reported improvement magnitude; no superior treatment identified.
Analysis details and source
Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.
Mental health
SF-36 mental component Points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Laser plus exercise | 20 | 38.7 (SD 9.1) | 43 (SD 8.2) |
| ESWT plus exercise | 20 | 43.5 (SD 12.4) | 45.4 (SD 7.9) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT change
Mann–Whitney U test of changes
No statistically significant difference in change between treatments.
Analysis details and source
Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.
Mental health
SF-36 mental component Points
| Group | n | Baseline | Reported change |
|---|---|---|---|
| Laser plus exercise | 20 | — | 4.4 (SD 6.5) |
| ESWT plus exercise | 20 | — | 1.9 (SD 9.9) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Laser versus ESWT
Mann–Whitney U
Source-reported improvement magnitude; no superior treatment identified.
Analysis details and source
Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.
How treatment was delivered
BTL-5000 SWT compressor POWER: 2,000 pulses, 2.0 bar, 10–15 Hz to the two most tender trapezius/paraspinal points; three sessions 5–8 days apart. Both groups received posture, range-of-motion and stretching exercises, three sets of ten daily at home for two months. The report does not explicitly classify the device as focused or radial.
Ga-As laser, 904 nm, 1.2 J/cm², 6 kHz for 30 seconds at the same two trigger points, 15 sessions over three weeks plus the same home exercises. There was no sham or exercise-only arm.
Adverse-event ascertainment and event counts are not reported. Authors declared no conflicts and no financial support. Ethics dates/codes differ between Methods and the closing ethics statement.
Completer analysis excludes six randomized patients; arm-specific attrition is not reported. No placebo/exercise-only arm separates treatment effects from exercise, expectation or natural change. The one-month horizon is short and masking/allocation details are missing. Demographic sex counts/percentages in Table 1 conflict internally and with the Results narrative; Table 2 prints an incomplete ESWT post-treatment BDI SD. These are not silently corrected.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- Completer analysis excludes six randomized patients; arm-specific attrition is not reported. No placebo/exercise-only arm separates treatment effects from exercise, expectation or natural change. The one-month horizon is short and masking/allocation details are missing. Demographic sex counts/percentages in Table 1 conflict internally and with the Results narrative; Table 2 prints an incomplete ESWT post-treatment BDI SD. These are not silently corrected.
Source-linked critical reading
Prospective randomized comparative study. Forty-six patients were allocated; six with missing assessments were excluded and 40 were analyzed. The random sequence, allocation concealment and assessor masking are not described.
Technical source record
Full local PDF read; All 7 PDF pages; Introduction; Methods; Results; Tables 1–3 including reporting inconsistencies; Discussion and limitations; Ethics; funding; conflicts; references
Both treatment packages were followed by less pain, and this study did not identify a superior one. Because everyone exercised and there was no inactive control, the improvement cannot be attributed entirely to the devices.
Does three-session shockwave therapy differ from 15-session laser therapy when both accompany exercise for chronic myofascial neck/back pain?
Prospective randomized comparative study. Forty-six patients were allocated; six with missing assessments were excluded and 40 were analyzed. The random sequence, allocation concealment and assessor masking are not described.
Patients with at least three months of neck/dorsal myofascial symptoms, diagnosed by Travell and Simons criteria, with trapezius or paraspinal trigger points; 20 analyzed per treatment. Mean age was 35.3 years. Fibromyalgia and severe cervical disc disease were excluded.
BTL-5000 SWT compressor POWER: 2,000 pulses, 2.0 bar, 10–15 Hz to the two most tender trapezius/paraspinal points; three sessions 5–8 days apart. Both groups received posture, range-of-motion and stretching exercises, three sets of ten daily at home for two months. The report does not explicitly classify the device as focused or radial.
Ga-As laser, 904 nm, 1.2 J/cm², 6 kHz for 30 seconds at the same two trigger points, 15 sessions over three weeks plus the same home exercises. There was no sham or exercise-only arm.
VAS pain on 0–10, algometer pressure pain threshold in kg, Beck Depression Inventory and SF-36 physical/mental components were measured before, after and one month after treatment. Table 2 gives means and SD; Table 3 reports improvement/change magnitudes and between-group tests.
At one month VAS fell from 6.8 to 3.1 with laser and 7.1 to 3.9 with ESWT. Reported improvement magnitudes were 3.7 versus 3.2 points (between-group p=.512). Pressure threshold rose to 3.7 versus 3.5 kg; BDI and physical SF-36 improved within groups, but none of the ten between-group outcome/time comparisons was significant. Mental SF-36 did not improve significantly within either group. Nonsignificance does not demonstrate equivalence.
Adverse-event ascertainment and event counts are not reported. Authors declared no conflicts and no financial support. Ethics dates/codes differ between Methods and the closing ethics statement.
Completer analysis excludes six randomized patients; arm-specific attrition is not reported. No placebo/exercise-only arm separates treatment effects from exercise, expectation or natural change. The one-month horizon is short and masking/allocation details are missing. Demographic sex counts/percentages in Table 1 conflict internally and with the Results narrative; Table 2 prints an incomplete ESWT post-treatment BDI SD. These are not silently corrected.
This addresses trapezius/paraspinal MPS with shared home exercise, not generalized fibromyalgia. Fewer shockwave visits may be practical, but neither equivalent efficacy nor cost-effectiveness was tested.
Use concealed allocation, blinded assessment, intention-to-treat analysis, an exercise-only/sham arm, longer follow-up and explicit adverse-event recording; correct demographic and ethics reporting inconsistencies.
Read the original article.
Comparison of the Efficacy of Laser and Extracorporeal Shockwave Therapy in Patients with Myofascial Pain Syndrome
Özyiğit E, Erdal A · Archives of Basic and Clinical Research · 2024
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →